Breast Cancer
📧 Sign up to get email alerts when something new happens for Breast Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-02-20Clinical Trial Update: Adding Adjuvant Cisplatin and Gemicitabine Versus Capecitabine in Triple-negative Breast Cancer Patients in Non pCR After Neoadjuvant Standard Chemotherapy [Phase 2, Phase 3]
Clinical trial evaluating adjuvant cisplatin plus gemcitabine versus capecitabine in triple-negative breast cancer patients who did not achi…
-
CLINICAL_TRIALS trial_result · 2024-02-16Clinical Trial Update: Treatment Patterns and Clinical Outcomes Among Talazoparib-Treated Adults With HER2-Negative mBC With gBRCA1/2m
Clinical trial update evaluating talazoparib-treated adults with HER2-negative metastatic breast cancer and germline BRCA1/2 mutations, repo…
-
CLINICAL_TRIALS trial_result · 2024-02-16Clinical Trial Update: Niraparib Plus Aromatase Inhibitors for Luminal-like(HER2-,ER+) and gBRCA or HDR+ Metastatic Breast Cancer (LUZERN) [Phase 2]
Phase 2 clinical trial update evaluating niraparib in combination with aromatase inhibitors for luminal-like, HER2-negative, ER-positive met…
-
CLINICAL_TRIALS trial_result · 2024-02-16Clinical Trial Update: Oral Paclitaxel Efficacy Safety and PK in Recurrent and Metastatic Breast Cancer [Phase 2]
Phase 2 clinical trial assessing the efficacy, safety, and pharmacokinetics of oral paclitaxel in recurrent and metastatic breast cancer has…
-
CLINICAL_TRIALS trial_result · 2024-02-16Clinical Trial Update: Repeatability of 68-GaNOTA-Anti-HER2 VHH1 PET/CT in Breast Carcinoma Patients [Phase 2]
Phase 2 trial evaluating the repeatability of 68-GaNOTA-Anti-HER2 VHH1 PET/CT in breast cancer patients, with the study status currently unk…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-02-15Clinical Trial Update: A Study of T-DXd for the Treatment of Solid Tumors Harboring HER2 Activating Mutations [Phase 2]
A Phase 2 clinical trial update shows results for trastuzumab deruxtecan (Enhertu) in solid tumors with HER2 activating mutations; the study…
-
CLINICAL_TRIALS trial_result · 2024-02-12Clinical Trial Update: Sunitinib in Treating Patients With Newly Diagnosed Stage II or Stage III Breast Cancer That Can Be Removed by Surgery [Phase 2]
Phase 2 clinical trial update evaluating sunitinib in newly diagnosed stage II/III breast cancer that can be removed by surgery.
-
CLINICAL_TRIALS trial_result · 2024-02-12Clinical Trial Update: Evaluate the Clinical Benefit of a Post-operative Treatment Associating Radiotherapy + Nivolumab + Ipilimumab Versus Radiotherapy + Capecitabine for Triple Negative Breast Cancer Patients With Residual Disease [Phase 2]
Phase 2 trial evaluating radiotherapy with nivolumab and ipilimumab vs radiotherapy with capecitabine for residual disease in triple-negativ…
-
CLINICAL_TRIALS trial_result · 2024-02-12Clinical Trial Update: Study of Dotatate Imaging in Breast Cancer [Phase 2]
Phase 2 clinical trial evaluating dotatate imaging in advanced breast cancer (Stage IV) is ongoing with status not specified.
-
CLINICAL_TRIALS trial_result · 2024-02-12Clinical Trial Update: Adaptive Training Exercise Programs for Improving Cardiorespiratory Fitness After Breast Cancer Treatment, The ACTIVATE Trial [NA]
A completed clinical trial evaluating adaptive training exercise programs to improve cardiorespiratory fitness after breast cancer treatment…
-
CLINICAL_TRIALS trial_result · 2024-02-09Clinical Trial Update: A Study of Pyrotinib Plus Capecitabine Combined With SRT in HER2+ MBC With Brain Metastases [Phase 2]
Phase 2 trial update evaluating pyrotinib plus capecitabine with stereotactic radiotherapy in HER2-positive metastatic breast cancer with br…
-
CLINICAL_TRIALS trial_result · 2024-02-08Clinical Trial Update: Efficacy and Safety of Fluzoparib Combined With Adjuvant Endocrine Therapy for HR+/HER2- SNF3-subtype Early Breast Cancer (BCTOP-L-A01) [Phase 3]
Phase 3 clinical trial evaluating fluzoparib plus adjuvant endocrine therapy for HR+/HER2- SNF3-subtype early breast cancer is currently rec…
-
CLINICAL_TRIALS trial_result · 2024-02-07Clinical Trial Update: Trastuzumab Deruxtecan (T-DXd) With Pyrotinib in First-line HER2-positive Unresectable or Metastatic Breast Cancer Trial [Phase 4]
Phase 4 trial update evaluating trastuzumab deruxtecan in combination with pyrotinib for first-line HER2-positive unresectable or metastatic…
-
CLINICAL_TRIALS trial_result · 2024-02-06Clinical Trial Update: Hypofractionated Radiation Therapy in Treating Patients With Stage 0-IIB Breast Cancer [Phase 2]
Phase 2 trial results for hypofractionated radiation therapy in Stage 0 to IIB breast cancer have been completed with results posted in 2024…
-
CLINICAL_TRIALS trial_result · 2024-02-06Clinical Trial Update: 4FMFES-PET Imaging of ER+ Advanced Breast Cancers [Phase 2]
Phase 2 clinical trial update evaluating 4FMFES-PET imaging in ER-positive advanced breast cancer.
-
CLINICAL_TRIALS trial_result · 2024-02-05Clinical Trial Update: CLI and FAR for Intraoperative Margin Assessment [Phase 2]
Phase 2 clinical trial update on intraoperative margin assessment for breast cancer using CLI and FAR technologies.
-
CLINICAL_TRIALS trial_result · 2024-02-02Clinical Trial Update: Neoadjuvant Treatment Pegylated Liposomal Doxorubicin Plus Cyclophosphamide Sequential Docetaxel Plus Trastuzumab and Pertuzumab Versus Docetaxel Plus Carboplatin Combined With Trastuzumab and Pertuzumab in HER-2 Positive Breast Cancer [Phase 3]
A Phase 3 trial evaluating neoadjuvant pegylated liposomal doxorubicin with cyclophosphamide followed by docetaxel with trastuzumab and pert…
-
CLINICAL_TRIALS trial_result · 2024-02-02Clinical Trial Update: A Long-term Follow-up Study for Cardiac Safety in the Patients With HER2 (+) Breast Cancer Who Have Completed the SB3-G31-BC
A long-term follow-up study assessing cardiac safety in HER2-positive breast cancer patients who completed SB3-G31-BC; study status terminat…
-
CLINICAL_TRIALS trial_result · 2024-02-01Clinical Trial Update: Atezolizumab Plus CArboplatin Plus Nab-paclitaxel [Phase 2]
Phase 2 trial investigating atezolizumab in combination with carboplatin and nab-paclitaxel for metastatic and triple-negative breast cancer…
-
CLINICAL_TRIALS trial_result · 2024-02-01Clinical Trial Update: Safety and Pharmacokinetics of ODM-209 [Phase 1, Phase 2]
Phase 1/2 trial update on safety and pharmacokinetics of ODM-209 for metastatic prostate cancer and advanced/metastatic breast cancer.
-
CLINICAL_TRIALS trial_result · 2024-01-30Clinical Trial Update: Pre-operative IRX-2 in Early Stage Breast Cancer (ESBC) [Phase 1]
Results from a Phase 1 pre-operative study of IRX-2 in early-stage breast cancer have been completed and posted, including cohorts with trip…
-
CLINICAL_TRIALS trial_result · 2024-01-30Clinical Trial Update: A Pre-operative Window Study of Letrozole Plus PR Agonist (Megestrol Acetate) Versus Letrozole Alone in Post-menopausal Patients With ER-positive Breast Cancer [Phase 2]
Phase 2 clinical trial comparing letrozole plus megestrol acetate vs letrozole alone as a pre-operative window study in postmenopausal ER-po…
-
CLINICAL_TRIALS trial_result · 2024-01-30Clinical Trial Update: Vaccination With Flt3L, Radiation, and Poly-ICLC [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating vaccination with Flt3L, radiation, and Poly-ICLC in cancer patients.
-
CLINICAL_TRIALS trial_result · 2024-01-26Clinical Trial Update: Efficacy Evaluation of Enobosarm Monotherapy in Treatment of AR+/ER+/HER2- Metastatic Breast Cancer [Phase 3]
Phase 3 trial evaluating enobosarm as monotherapy for AR+/ER+/HER2- metastatic breast cancer has been terminated.
-
CLINICAL_TRIALS trial_result · 2024-01-25Clinical Trial Update: TA(E)C-GP Versus A(E)C-T for the High Risk TNBC Patients and Validation of the mRNA-lncRNA Signature [Phase 2, Phase 3]
Phase 2/Phase 3 clinical trial update comparing TA(E)C-GP to A(E)C-T in high-risk triple-negative breast cancer with validation of an mRNA-l…